Article discusses the conflicts – do these payments affect prescribing patterns? Certainly an issue in a case involving a patient with several treatment options, the most effective not being that for which his/her doctor is paid.
http://www.nytimes.com/2011/11/25/us/payments-to-doctors-by-pharmaceutical-companies-raise-issues-of-conflicts.html?_r=1&ref=health